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Functional health literacy is founded on general and numerical literacy and practical 
skills, and is required for the appropriate and effective management of health symptoms 
in children. This study aimed to assess the health literacy skills of parents and 
caregivers of preschool-aged children, using a progressive scenario describing a child 
with fever and presenting tasks relating to selection of a medicine and hypothetical 
dosing of their child. Participants (n=417) from 33 childcare- and health-related sites in 
Sydney, Brisbane, Melbourne and Auckland completed the study. Participants’ 
responses were largely appropriate regarding actions in response to worsening 
symptoms, selection of an appropriate product (from a limited range), whereby 84.5% 
of responses were for a single-ingredient paracetamol product, and use of the package 
directions to state the frequency of dosing (93.1% of frequencies appropriate for 
paracetamol, 66.7% for ibuprofen). However, in only 50.8% of cases was an appropriate 
weight-based dose calculated, and doses were not measured to within 10% of the stated 
dose in 16.7% of cases. Future studies should focus on skill development via 









Health literacy refers to the abilities of individuals to obtain, understand and apply (or 
interpret) health care information in written, spoken or digital format, and subsequently 
make appropriate health-related decisions (Adams et al., 2009a; Finset and Lie, 2010; 
Jordan et al., 2010). Health literacy impacts an individual’s ability to access health care 
and adhere to therapeutic treatment (DeWalt and Hink, 2009). It is estimated that 
around nine million Australians – nearly half of the population – have inadequate health 
literacy (Adams et al., 2009b). Limited health literacy affects the daily lives of 
individuals; they may ask fewer questions because health information may seem too 
difficult to understand, and they often misinterpret health-related instructions (Adams et 
al., 2009b).   
 
Health literacy skills are required for the optimal care of young children, where parents 
or caregivers must interpret the child’s symptoms and make responsible decisions about 
management of those symptoms. This includes when and how to administer medicines, 
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selection or calculation of an appropriate dose, measurement of that dose, determination 
of repeat dosing intervals, and decisions regarding when further medical attention is 
warranted. The most common medicine used in children from birth to two years of age 
in Australia is paracetamol (Trajanovska et al., 2010). However, studies suggest that the 
common use of paracetamol is associated with a large proportion of accidental 
paediatric overdoses (Daly et al., 2008), most of which would be averted with 
awareness of its appropriate use. In a study in California, 62% of paracetamol doses 
measured by parents were inaccurate (Sobhani et al., 2008). This may be related to 
differing product strengths, types of measuring devices and the increments on the 
measuring devices (Sobhani et al., 2008; Yin et al., 2010). These studies suggest that 
choosing the correct product and dose for children are difficult tasks for parents and 
caregivers (Sobhani et al., 2008; Yin et al., 2010). These types of decisions, founded on 
general and numerical literacy and practical skills, are indicators of functional health 
literacy. The principles of ‘Quality Use of Medicines’ – safe, effective, appropriate and 
judicious use of medicines (Australian Government Department of Health and Ageing, 
2011) – is important in all populations, and may be more challenging to achieve in the 
paediatric population.  
 
Various measuring devices are available to assist with administration of liquid 
medications to children; some devices are incorporated into the medicine’s packaging. 
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The oral syringe is the most accurate measuring device for liquid medicines (Yin et al., 
2010);
 
other advantages are reduced risks of gagging, spillage and aspiration when 
dosing the child (Madlon-Kay and Mosch, 2000).
 
Measuring cups are reportedly five 
times less accurate than syringes (Sobhani et al., 2008; Yin et al., 2010), although cups 
are commonly supplied with medicines (Yin et al., 2010). Household teaspoons are the 
least accurate device (Sobhani et al., 2008). However, a study in New Zealand that 
explored parents’ perceptions of dosing devices reported that teaspoons were the most 
commonly-used device for administering medicines to children aged three to six years 
(Kairuz et al., 2007). 
  
Researchers in Sydney, Australia pilot tested a method to determine the ability of 
caregivers to discern the severity of children’s symptoms when presented with a 
scenario describing a fever. Additionally, the caregivers were asked to select an 
appropriate medicine and measure an appropriate dose for a child. This method was 
then repeated at an additional three research centres with varying, but complementary, 
sampling approaches. This paper reports the findings from the combined data from the 
four research centres. The aim of this analysis was to determine the key health literacy 
issues relating to management of children’s fever by caregivers, assessed using a series 







The study was conducted between August 2009 and February 2010 by pharmacy 
students at three universities in Australia and a fourth in New Zealand, under the 
guidance of academic supervisors. The study was initiated with one pair of researchers 
from The University of Sydney (denoted as ‘Sydney’), followed by three pairs from The 
University of Auckland (‘Auckland’), four pairs from The University of Queensland 
(‘Brisbane’), and two pairs from Monash University (‘Melbourne’).  
 
Data were collected from 33 sites in total, sampled for convenience, yet reflecting a 
range of childcare settings in areas expected to have a high proportion of young 
families; participants of varying health literacy were expected. In Sydney, parents and 
childcare workers were sampled from seven day-care centres in suburbs varying in 
socio-economic characteristics.  Fifteen day-care centres were recruited in Melbourne, 
two in Brisbane and four in Auckland. The study also involved two community 
pharmacies in both Brisbane and Auckland. The remaining site was a surgical day-stay 




At each site, data were collected from parents, caregivers and/or childcare workers 
recruited from these various settings. In all cases, the manager of the data collection site 
was approached by telephone or in person, and provided written consent to host the 
researchers. The parents, caregivers and/or childcare workers invited to participate from 
each of the Australian sites provided verbal consent, and in New Zealand and Sydney, 
provided written consent to participate. Inclusion criteria required participants to be a 
caregiver for a child under six years of age and fluent in English. The study was 
approved by the relevant university or health ethics committee(s) at each centre.  
 
Data collection was standardised using an instrument developed at The University of 
Sydney based on a review of the literature. The instrument comprised a hypothetical 
‘fever’ scenario and participants considered their child or children under the age of six 
years as the subject(s) of the scenario (Appendix 1). The scenario was designed to be 
progressive, in that the participant’s child hypothetically had worsening symptoms, to 
identify the point at which the participant would administer a medicine for symptomatic 
relief. At that step, participants were asked to select a product from a range of 14 liquid 
non-prescription medicines (Table 1) which represented leading brands for management 
of common childhood ailments in both countries. Participants’ preferences for 
alternative products or brands were noted, while those who indicated that they would 




Where appropriate, participants determined the dose for their child(ren), selected the 
measuring device that they would normally use from the range of syringes, medicine 
cups and spoons provided, and measured the dose. Participants’ preferences for other 
measuring devices were noted. The measured dose was confirmed by a researcher at 
three of the four research centres (dosing errors were not calculated in the Melbourne 
sample) either visually or by drawing the dose into a syringe. The measured dose was 
then returned to the bottle, and the measuring device was rinsed and dried for further 
use. Participants were asked whether they would give a second dose, and if so, at what 
time interval.  
 
Demographic data collected included the participant’s formal education, number of 
children, the birth order of the child in this study, and the child’s gender, date of birth, 
weight and any other medical conditions. Minor variability between research centres in 
the manner of data collection was in accordance with requirements of the respective 
ethical committees. The researchers at each site were trained to conduct the scenario-
based interview by their supervisors at each centre and practice interviews were 
conducted to ensure that data were collected competently and consistently. Researchers 
conducted the interviews in pairs, with both recording the participants’ responses and 
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independently confirming and agreeing upon dose volumes to reduce error and increase 
reliability. For practical reasons, non-participation was not monitored. 
 
Data spreadsheets from each research centre were compared and merged, with 
descriptive univariate and bivariate analysis undertaken using SPSS
®
. The analyses 
reported here are the responses to a series of medication-related decisions and tasks 
performed by caregivers of young children, as indicators of functional health literacy in 
caregivers. Differences in proportions were calculated using chi-square, with p<0.05 
indicating statistical significance. Differences according to characteristics of the child 




The study involved 534 responses from 417 participants (range 3-38 responses per data 
collection site, and 95-207 per research centre). The children considered as the subjects 
of the scenarios were male in 51.5% of cases, and were predominantly one to four years 
of age (63.0%). Other demographic data, collected in the majority of research sites, 
indicated that 85.5% (219/256) of the responses were from parents (as opposed to 
caregivers), while 42.3% of families represented in the sample (167/395) were single-
child families and 43.8% comprised two children (173/395). The child referred to as the 
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subject of the scenario was the first-born in 53.8% of cases (229/426). As a surrogate 
measure of socio-economic status, 71.9% of responses (307/434) were from participants 
who held a tertiary (university) qualification, and 75.3% of responses were from 
participants (293/389) in some level of paid employment. 
 
An increasing proportion of participants elected to ‘give a product’ as the three stages of 
the fever scenario progressed. In the first stage, where the child felt “hot and slightly 
irritable”, 14.7% (61/416) of responses were to dose the child. This response increased 
to 55.0% (198/360) at the second stage, where the subject had “a temperature of 37.9°C 
but was still playing, eating and drinking,” and further increased to 62.6% (142/227) at 
the third stage, where the subject had “a temperature of 39.1°C and symptoms of 
lethargy and irritability.” As the scenario progressed, the proportion of responses 
indicating referral to a doctor also increased, from 0.7% to 5.0% to 30.4%. There was 
no significant trend in these responses according to whether the child was first born or 
later (p<0.05). 
 
When identifying the medicine with which they would dose the child, 84.5% of 
responses (331/393) were to select a single-ingredient paracetamol medicine (Table 2), 
predominantly Panadol
®
 1-5 years.  In half of the responses in which a medicine was 
chosen (50.8%, 128/252), the parent/caregiver identified a dose that was deemed by the 
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researcher to be suitable for the child’s weight (or age, if this was the only known 
variable). Incorrect dose calculation was noted in particular in the Auckland group 
(p<0.01), at 70.6% of their sample (84/119), compared to 33.3% (14/42) in the 
Queensland and 28.6% (26/91) in the Sydney group.  
 
When participants were asked to choose a device to measure the dose they had 
determined, the most common device chosen was the 5mL oral syringe. Participants 
generally chose an oral syringe or dropper to measure small doses (Table 3). Of the 
doses in the range of 0-1.9mL, 28 of 33 participants selected a syringe, while the 
remainder chose a dropper. Conversely, medicine cups were generally chosen to 
measure larger doses of medication. One interesting finding, however, was that 19 of 45 
participants measuring a dose of at least 10mL elected to use a 5mL oral syringe. The 
most common range of doses that participants measured using spoons (a medicine 
spoon or household teaspoon) was 4.0-5.9mL. The researchers’ verification of the 
measured dose indicated that one in six of the parents/caregivers (16.7%) measured a 
dose that was outside a 10% error margin of the intended dose. Chi-square analysis 
revealed that respondents’ ability to accurately measure the required dose was unrelated 




A repeat dose would be given after four to six hours by the majority of participants 
selecting a paracetamol-containing medicine (93.1%, 190/204), and six to eight hours 




This research presents a novel insight into the practical management of childhood fever 
by parents or caregivers of a child aged less than six years. The participants were guided 
through a progressive scenario based on management of their child, culminating in 
dosage measurement tasks. Collectively, these responses could be considered measures 
of functional health literacy (Adams et al., 2009a, 2009b) incorporating decision 
making about the point at which medical intervention was required, selecting an 
appropriate medicine, numeracy skills in determining an appropriate dose, and practical 
skills in selecting an appropriate measuring device and measuring the required dose. By 
comparison, other measures of functional health literacy reported in the literature 
include the Newest Vital Sign assessment (Weiss et al., 2005), involving consumers’ 
interpretation of a nutrition panel of a packaged food, the Parent Health Literacy 
Activities test, involving 20 questionnaire items relating to infant care (Kumar et al., 
2010), and tasks requiring medicine consumers to interpret a dispensed medicine label 
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(Emmerton et al., 2012). Subsequent research could engage participants in combinations 
of practical and paper-based exercises to contribute to validation of the measures. 
  
This research method accommodates individual variability between the respondents, as 
the scenario focused the participants’ attention on a familiar subject of the scenario 
(their child), and the intended dose was identified or calculated with respect to that 
child’s age or weight. This offers some advantages over a standardised case study 
presented to all respondents, in that, for example, a parent of a young baby would not be 
asked to calculate and measure a dose for a hypothetical five-year-old child. There was 
minor variability in the research conduct and data entry between research centres, 
particularly in the range of sites recruited by each centre; this was considered to add 
richness to the data. The four datasets combined for analysis were standardised by 
including only common variables and were checked by a supervisor at each centre 
before merging. Similar research by Yin et al. (2010) was a single-site study in New 
York, reporting the accuracy of parents’ measurement of liquid medicines not 
associated with a scenario to explore other aspects of health literacy. Another limitation 
is that the hypothetical scenarios might not reflect actual practice; despite the 
participants remaining anonymous, their responses may have been tempered by virtue 
of being observed by the researchers. Further, for brevity, our research did not include a 
validated measure of health literacy for comparison of the data from the practical tasks. 
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A subsequent study, designed to engage participants for a longer period of time at their 
convenience and powered to detect differences between subgroups of participants, may 
explore such a comparison, given that our data are suggestive of variable functional 
health literacy. Findings may not be generalisable to the wider population, given that 
characteristics of non-participants were not documented.  
 
 
The fever scenario was presented in three stages, with the intention that a product 
‘should’ be given at the third stage, when the fever reaches 39.1°C and the child has 
symptoms of lethargy and irritability (Russell et al., 2003). The majority of participants 
had decided that the subject should be dosed by that stage, with just over half of them 
electing to dose their child prior to this when the fever was less than 39.0°C and the 
symptoms were mild. There is controversy surrounding reduction of fever in children, 
in that fever itself may not be harmful (Russell et al., 2003). However, it is recognised 
that fever may be associated with fatigue, arthralgia and myalgia, and may result in 
tachycardia, tachypnoea and febrile convulsion (Pearce and Curtis, 2005), and the 
World Health Organization recommends the use of paracetamol for children with a 
fever greater than 39.0°C (Russell et al., 2003). Paracetamol was found to be the 
ingredient of choice for the majority of our participants, consistent with research by 
Chiappini et al. (2012) in a survey of parents of preschool children in Italy. Ibuprofen is 
recognised as a valid choice for fever reduction, with a similar safety profile to 
15 
 
paracetamol (Perrott et al., 2004; Southey et al., 2009), and is marketed in Australia for 
infants over three months of age. Indeed, some research has reported ibuprofen to be 
more effective in reducing fever than paracetamol (Hay et al., 2009; Perrott et al., 
2004). The present study did not explore reasons for preferences or the participants’ 
product familiarity. 
 
It is a concern that half of the participants identified an inappropriate dose. This is an 
aspect of health literacy that warrants further investigation: do parents/caregivers not 
‘see’ the information, are they unable to comprehend or apply it, do they use doses 
recommended by others, or do they deliberately contradict the product directions? The 
labels of all of the antipyretic (fever-reducing) medicines presented to the participants 
listed doses by weight; however, only half of the participants identified an appropriate 
dose for the child’s weight when this was known. While manufacturers’ doses are 
presented as ranges to account for the body weight and composition of individual 
children, and inaccuracy in measuring devices is inherent, it should be borne in mind 
that under-dosing is therapeutically ineffective, and repeated over-dosing risks toxicity 
in paediatric patients.  It is interesting to note that appropriate dosing with paracetamol 
in obese children is best determined by their ‘ideal weight’ rather than their actual 
weight. If using the actual weight to determine the dose for an obese child, this may 
lead to an overdose of the medication and risks of hepatotoxicity (NSW Health 
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Department, 2008). Despite the rising trend in childhood obesity (ABS, 2011; AIHW, 
2004), our study did not determine the prevalence of overweight children in our sample, 
and therefore whether this adjustment should apply to the participants’ child.
 
 
There are advantages and disadvantages of dosing regimens based on age or weight. 
Age-based regimens have the advantage of being used easily in a practical setting 
(Bartelink et al., 2006), and doses are simple to determine. However, they do not 
account for the variability of pharmacokinetics of individuals over the range of ages 
(Bartelink et al., 2006). Body weight-based regimens have the advantage that 
pharmacokinetic factors are commonly founded on weight rather than age, but may 
overdose children who are obese, and therefore, there is a need for a maximum dosage 
to be determined (Bartelink et al., 2006).
 
 
It was reassuring to note that the majority of participants recognised the pattern of 
increasing seriousness in the scenario. For those who indicated medical intervention 
such as taking the subject to a medical practitioner or hospital at the most serious stage, 
it was unclear whether they would give a medicine in the interim. A limitation of the 
study was requesting participants to nominate a single action. Walsh and colleagues 
(2007) identified that parents may perform multiple or stepwise actions in response to 
fever symptoms, that they initiated antipyretic medication at a temperature anywhere 
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from 37.0 to 40.0 degrees Celcius (mean 38.3 degrees), and that some parents alternated 
antipyretics when one medicine was considered ineffective, a practice that is supported 
by some health professionals, but can lead to overdosing and is not recommended by 
Health authorities (NSW Health, 2010). Similarly, Chiappini et al. (2012) reported that 
around one in five parents would alternate dosing with two antipyretic medicines, yet 
favoured physical methods for reduction of a mild fever. Another limitation was that the 
scenario did not indicate how the child’s temperature had hypothetically been taken 
(e.g. mouth, armpit), and whether parents/caregivers recognised that this can influence 
the thermometer reading (Pearce and Curtis, 2005). 
 
Syringes and droppers, generally chosen to measure smaller doses of medications, were 
appropriate choices (Yin et al., 2010; Chiappini et al., 2012) for measurement of the 
medicines in this study. Measuring larger doses (at least 10mL) using a 5mL oral 
syringe, as reported for 19 of 45 participants, introduces measurement error. Despite 
presenting a range of standard medicine measures, it was surprising that eight 
respondents chose to use a household teaspoon, recognised as the least accurate measure 
(Madlon-Kay and Mosch, 2000; Sobhani et al., 2008). A teaspoon’s capacity can vary 




The ability of most parents or caregivers to state the correct dose interval for 
paracetamol, if another dose were to be given, largely reflected the directions on the 
packaging of the respective products. More frequent dosing, as noted more commonly 
for ibuprofen, was presumed related to its longer stated dose interval (6-8 hourly 
compared to 4-6 hourly for paracetamol). This finding confirms the inappropriate 
dosing for children’s fever reported by Walsh et al. (2007). Although this information is 
provided on the medicine packaging, it should be noted that continuous dosing of either 
paracetamol or ibuprofen at their respective specified dosage interval could exceed the 




Responsible and effective management of an unwell child requires a range of functional 
health literacy skills. In this scenario-based study conducted across 33 health or care-
related sites, the ability of parents/caregivers to identify when it would be appropriate to 
administer a medicine, and to accurately identify and measure the dose, produced mixed 
findings. Positive findings were participants’ response to the worsening symptoms, 
selection of an appropriate product (from a limited range) and use of the package 
directions to state the frequency of dosing. Findings of concern were the participants’ 
determination of appropriate weight-based doses, and, to a lesser extent, selection of 
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appropriate medicine measure and measurement of an accurate dose. Skill development 
of caregivers is recommended, via educational campaigns and coaching by healthcare 
providers. An international comparison of fever management guidelines versus practice 
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Table 1: Products Available for Selection by Participants (Australian Research 
Centres*) 
 
Product Active Ingredient/s 
Panadol
®
 Infant Paracetamol 100mg/1mL 
Panadol
®
 1-5 years Paracetamol 120mg/5mL 
Panadol
®
 5-12 years Paracetamol 240mg/5mL 
Nurofen
®




Ibuprofen (1-5years) 100mg/5mL 
Ibuprofen (5-12 years) 200mg/5mL 
Dymadon
®
 Infant (1 month to 2 years) Paracetamol 50mg/1mL 
Dymadon
®
 Children ( 2 years - 12 years) Paracetamol 250mg/5mL 
Dimetapp
®












Chlorpheniramine maleate 1.25mg/5mL 
Phenylephrine hydrochloride 2.5mg/5mL 




Brompheniramine maleate 2mg/5mL 
Phenylephrine hydrochloride 5mg/5mL 
Dextromethorphan hydrobromide 10mg/5mL 
Claratyne
®
 Loratadine 5mg/5mL 
Zyrtec
®
 Cetirizine 5mg/5mL 
Phenergen
®
 Promethazine hydrochloride BP 5mg/5mL 





Table 2: Fever Medicine Selected by Participants 
 
Ingredient and Formulation n* % 
Paracetamol 331 84.2 
  Infant formula 100mg/1mL (n=72)     
  Children 120mg/5mL (n=257)     
  Unspecified (n=2)     
Ibuprofen 61 15.5 
  Infant 100mg/5mL (n=14)     
  Children 100mg/5mL  (n=47)     
Paracetamol + ibuprofen 1 0.3 
Total   393 100.0 





Table 3: Measuring Device Selected by Participants 
 
0-1.9 % 2-3.9 % 4-5.9 % 6-7.9 % 8-9.9 % >=10 % Total* %
Oral Syringe (5mL) 28 84.8 28 87.5 44 63.8 44 73.3 20 44.4 19 42.2 183 64.4
Medicine Cup 0 0.0 1 3.1 10 14.5 13 21.7 24 53.3 25 55.6 73 25.7
Medicine Spoon 0 0.0 1 3.1 8 11.6 1 1.7 0 0.0 0 0.0 10 3.5
Teaspoon 0 0.0 1 3.1 5 7.2 1 1.7 0 0.0 1 2.2 8 2.8
Dropper 5 15.2 1 3.1 0 0.0 0 0.0 1 2.2 0 0.0 7 2.5
Spoon Cup Hybrid 0 0.0 0 0.0 1 1.4 1 1.7 0 0.0 0 0.0 2 0.7
Other 0 0.0 0 0.0 1 1.4 0 0.0 0 0.0 0 0.0 1 0.4
Total 33 100.0 32 100.0 69 100.0 60 100.0 45 100.0 45 100.0 284 100.0














Infant Children Unspecified Total* Infant  Children Total* 
1 0 (0.0%) 3 (1.5%) 0 (0.0%) 3 (1.5%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 
2 1 (0.5%) 1 (0.5%) 0 (0.0%) 2 (1.0%) 0 (0.0%)  1 (2.0%)  1 (2.0%) 
3 2 (1.0%) 2 (1.0%) 0 (0.0%) 4 (2.0%)  1 (2.0%) 2 (3.9%) 3 (5.9%) 
4 52 (25.5%) 96 (47.1%) 2 (1.0%) 150 (73.5%)  1 (2.0%) 12 (23.5%) 13 (25.5%) 
5 2 (1.0%) 4 (2.0%) 0 (0.0%) 6 (2.9%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 
6 9 (4.4%) 25 (12.3%) 0 (0.0%) 34 (16.7%) 5 (9.8%) 21 (41.2%) 26 (51.0%) 
7 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)  1 (2.0%)  1 (2.0%) 
8 1 (0.5%) 3 (1.5%) 0 (0.0%) 4 (2.0%) 0 (0.0%) 7 (13.7%) 7 (13.7%) 
12 0 (0.0%) 1 (0.5%) 0 (0.0%) 1 (0.5%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 
Total 67 (32.8%) 135 (66.2%) 2 (1.0%) 204 (100.0%) 7 (13.7%) 44 (86.3%) 51 (100.0%) 





Appendix 1: Fever Scenario 
 
 
Name of Child:____________________ 
Age of Child: _____________________ 
Weight of Child (kg):__________________ 
 
SCENARIO 
1. Your  x year old child feels hot and is a bit irritable. What would you do? 
 Take a temperature – step 2 
 Give a product – step 3 
 Watch for more signs – step 2 
 Nothing – step 2 
 Doctor 
 Accident & Emergency 
 other: _________________________________________________ 
 
2. The child’s temperature is 37.9 degrees Celsius. What do you do? 
 Give a product – step 4 
 Watch for more signs – step 3 
 Nothing – step 4 
 Doctor 
 Accident & Emergency 
 other: _________________________________________________ 
 
3. Later, the child’s temperature is 39.1 degrees Celsius. What do you do? 
 Give a product – step 4 
 Nothing – step 4 
 Doctor 
 Accident & Emergency 




4. Select a product, state a dose for your child, select a measuring device and then measure the 
intended dose.: 
 Product selected: 
 Panadol Infant 
 Panadol 1-5 years 
 Panadol 5-12 years 
 Nurofen for Infants 
 Nurofen  
 Dymadon Infant 
 Dymadon Children 
 Dimetapp 
 Dimetapp DM 
 Demazin Cold 
 Demazin Cough & Cold 
 Other: _____________________________ 
 Dose stated by parent:________________ 
 Device used: 
 oral syringe 
 measuring cup 
 teaspoon 
 other: _______________________________ 
 Quantity measured:_____________________ 
 
5. If you were to give another dose of this medicine, how much time would you leave between 
doses?_________________ 
 
6. Would you give any other medicines in the next 24 hours? 
_______________________________________________________________________________
_______________________________________________________________________________ 
 
 
 
 
 
 
 
 
Notes: 
